current
EVENTS
no scheduled EVENTS
previous
EVENTS
Tuesday, April 13 2021
congressional directed medical research program
(CDMRP) CANCER PROGRAMS
The Department of Defense’s Congressional Directed Medical Research Program (CDMRP) includes a variety of different cancer research grant opportunities, which sometimes makes it difficult to choose the best program given that research often involves several different types of cancers. In this webinar, researchers will hear from the program leads for several programs to better understand which program is the best fit for their specific grant application and why.
Speakers:
• Nicole Williams, Ph.D. - Program Manager Pancreatic Cancer Research Program and Autism Research Program
• Sagar Ghosh, Ph.D. - Program Manager Rare Cancer Research Program and Ovarian Cancer Research Program
• Donna M. Kimbark, Ph.D. - Program Manager Peer Reviewed Cancer Research Program and Melanoma Research Program
In addition to providing a general overview of the CDMRP, the following programs will be highlighted:
-
Peer-Reviewed Cancer Research Program (PRCRP)
-
Ovarian Cancer Research Program (OCRP)
-
Rare Cancer Research Program (RCRP)
-
Pancreatic Cancer Research Program (PACRP)
SHEPHERD was proud to co-sponsor the following webinar along with The American Gastroenterological Association, The Deadliest Cancers Coalition, and The Defense Health Research Consortium
Wednesday, October 28, 2020
turning advocacy
INTO ACTIVISM
In that pivotal moment when the need for urgency can no longer be denied and the status quo can no longer be accepted, your voice is the most powerful tool you have to enact change. Join us to learn how to influence Congress, hone your story and create major impact from a Nobel Peace Prize nominee for her effective activism, a global communications expert, a Capitol Hill staffer, and two powerful activists who are a patient and a caregiver.
Topics:
-
Why your individual voice matters and the power behind galvanizing a community
-
How to formulate your own story to influence impactful and meaningful change
-
Do's and Don’ts from a Congressional viewpoint
-
Lessons learned from starting a civil rights movement from a Nobel Peace Prize nominee
-
How to conduct effective advocacy to move legislation in Congress
Watch Now
Jace Ward
DIPG Patient & Advocate
Amanda Nguyen
CEO and founder of Rise
Gillian Parrish
Healthcare Communications Expert
Adeola Adesina
Health Policy Advisor at the US House of Representativest
BrandiLee Schafran
Director of Patient Advocacy SHEPHERD Foundation
Presentations
Adeola Adesina
Health Policy Advisor at the US House of Representativest
Gillian Parrish
Healthcare Communications Expert
Wednesday, September 30, 2020
rare cancer day
CONGRESSIONAL BRIEFING
Did you know that rare cancer is anything but rare? Ninety-five percent (380 out of 400) of all forms of cancer are rare. That means that more than 500,000 people this year will be diagnosed with some form of rare cancer, yet research and treatment for rare cancers are funded at a significantly lower rate than for those cancers considered common. All pediatric cancers are considered rare and minority groups and veterans are disproportionately affected. The system is broken. Too many lives have been altered. Too many lives have been lost.
This event included a panel presentation by diverse leaders in the field of rare cancer, including patients, oncologists and researchers. You will learn the facts about rare cancer, the gaps in current treatment and research systems, and policy recommendations for addressing them.
Watch Now
